LYFE Capital
Finance · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
3000 Sand Hill Rd Ste 2-130, Menlo Park,...Phone Number
(650) 352-7588Website
www.lyfecapital.comRevenue
<$5 MillionIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
3
2
2
2
About LYFE Capital
LYFE Capital is a premier healthcare investment platform that connects healthcare champions with global markets, supply chains, and strategic partners. The company focuses on investing in critical healthcare supply chain assets, specialized product platforms, and next-generation R&D services, aiming to generate significant and resilient revenues from mature global markets. With a presence in five global offices across Asia and the U.S., LYFE Capital seeks to scale high-potential businesses and deliver consistent returns to institutional investors. Their portfolio includes a diverse range of healthcare companies, emphasizing innovation and growth in the healthcare sector.Explore more
LYFE Capital Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LYFE Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once LYFE Capital has new funding data
Congratulate Masked Content for being promoted to Masked Content at LYFE Capital
Check if LYFE Capital has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when LYFE Capital launches new products
Check out if LYFE Capital is spiking on competitors!
Earning: See what the market has to say on LYFE Capital recently announced quarterly report
Click to see if LYFE Capital had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
LYFE Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to LYFE Capital
Compare insights from companies similar to LYFE Capital, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
LYFE Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
LYFE Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about LYFE Capital.
LYFE Capital financials insights
Gather financial insights about LYFE Capital, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$55M
LYFE Capital Tech Stack
A closer look at the technologies used by LYFE Capital
Most Recent Scoops
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
Project
Spending/Investment
LYFE Capital News & Media
CytoTronics Secures $13.5M Series Seed 2 Financing to Speed Market Entry of Pixel System for Breakthroughs in Cell Biology
BOSTON--(BUSINESS WIRE)-- #BioTech--CytoTronics secures $13.5 million in seed extension financing and appoints Sameer Rohatgi of LYFE Capital to its Board of DirectorsNeurona Therapeutics Raises $120M in Funding
Neurona Therapeutics, a San Francisco, CA-based clinical-stage biotherapeutics company, raised $120M in funding. The round was led by Viking Global Investors and Cormorant Asset Management with participation from new and existing investors, including The Column Group, LYFE Capital, Schroders Capital, Willett Advisors, Ysios Capital Partners, Euclidean Capital, SymBiosis, Alexandria Venture Investments, Berkeley Frontier Fund, Sphera […] The post Neurona Therapeutics Raises $120M in Funding appeaiECURE Raises $65 Million to Advance In Vivo Gene Editing Programs for the Treatment of Rare Pediatric Liver Diseases
PHILADELPHIA--(BUSINESS WIRE)--iECURE, a gene editing company focused on the development of mutation-agnostic in vivo gene insertion, or knock-in, editing therapies for the treatment of liver disorders with significant unmet need, announced today the completion of a $65 million Series A-1 financing. The Series A-1 financing was co-led by Novo Holdings A/S and LYFE Capital with significant participation from existing investors Versant Ventures and OrbiMed Advisors. This financing, coupled with tMediLink Therapeutics closes US$70 million Series B financing
SUZHOU, China, March 14, 2022 /PRNewswire/ -- MediLink Therapeutics (Suzhou) Co., Ltd (MediLink) recently announced completion of a US$70 million Series B financing. This round was led by LYFE Capital and Qiming Venture Partners, and co-invested by Legend Capital, Loyal Valley Capital and...
Read more news
Top Finance Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LYFE Capital
Sign Up For FreeTo access detailed company insights
LYFE Capital is a premier healthcare investment platform that connects healthcare champions with global markets, supply chains, and strategic partners. The company focuses on investing in critical healthcare supply chain assets, specialized product platforms, and next-generation R&D services, aiming to generate significant and resilient revenues fr... Read More
